242 related articles for article (PubMed ID: 33672607)
1. Unmet Medical Needs and Future Perspectives for Leiomyosarcoma Patients-A Position Paper from the National LeioMyoSarcoma Foundation (NLMSF) and Sarcoma Patients EuroNet (SPAEN).
Kasper B; Achee A; Schuster K; Wilson R; van Oortmerssen G; Gladdy RA; Hemming ML; Huang P; Ingham M; Jones RL; Pollack SM; Reinke D; Sanfilippo R; Schuetze SM; Somaiah N; Van Tine BA; Wilky B; Okuno S; Trent J
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33672607
[TBL] [Abstract][Full Text] [Related]
2. What Clinical Trials Are Needed for Treatment of Leiomyosarcoma?
Kasper B; D'Ambrosio L; Davis EJ; Ingham M; Broto JM; Trent JC; van Houdt WJ; Van Tine BA
Curr Treat Options Oncol; 2022 Mar; 23(3):439-449. PubMed ID: 35275323
[TBL] [Abstract][Full Text] [Related]
3. EJSO educational Special issue from the TARPSWG - Standard medical treatment and new options in retroperitoneal sarcoma.
Kasper B; Baldi GG; Loong HH; Trent J
Eur J Surg Oncol; 2023 Jun; 49(6):1133-1139. PubMed ID: 34998634
[TBL] [Abstract][Full Text] [Related]
4. Global Patient Involvement in Sarcoma Care-A Collaborative Initiative of the Connective Tissue Oncology Society (CTOS) & Sarcoma Patients EuroNet (SPAEN).
Kasper B; Schuster K; Wilson R; Bickley S; Blay JY; Reinke D; Wartenberg M; Haas R
Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205602
[TBL] [Abstract][Full Text] [Related]
5. An update on the management of sporadic desmoid-type fibromatosis: a European Consensus Initiative between Sarcoma PAtients EuroNet (SPAEN) and European Organization for Research and Treatment of Cancer (EORTC)/Soft Tissue and Bone Sarcoma Group (STBSG).
Kasper B; Baumgarten C; Garcia J; Bonvalot S; Haas R; Haller F; Hohenberger P; Penel N; Messiou C; van der Graaf WT; Gronchi A;
Ann Oncol; 2017 Oct; 28(10):2399-2408. PubMed ID: 28961825
[TBL] [Abstract][Full Text] [Related]
6. Setting the international research agenda for sarcoma together with patients and carers: first results of the Sarcoma Patient EuroNet (SPAEN) priority setting partnership.
Husson O; Drabbe C; Schuster K; van Kampen P; Koops C; Weidema M; Davidson R; Wartenberg M; Artzner E; Gonzato O; Fernandez N; Kasper B; Pilgermann K; Wilson R; van der Graaf WTA; van Oortmerssen G
ESMO Open; 2022 Jun; 7(3):100509. PubMed ID: 35714479
[TBL] [Abstract][Full Text] [Related]
7. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
8. Management of sporadic desmoid-type fibromatosis: a European consensus approach based on patients' and professionals' expertise - a sarcoma patients EuroNet and European Organisation for Research and Treatment of Cancer/Soft Tissue and Bone Sarcoma Group initiative.
Kasper B; Baumgarten C; Bonvalot S; Haas R; Haller F; Hohenberger P; Moreau G; van der Graaf WT; Gronchi A;
Eur J Cancer; 2015 Jan; 51(2):127-36. PubMed ID: 25434922
[TBL] [Abstract][Full Text] [Related]
9. Epithelioid hemangioendothelioma, an ultra-rare cancer: a consensus paper from the community of experts.
Stacchiotti S; Miah AB; Frezza AM; Messiou C; Morosi C; Caraceni A; Antonescu CR; Bajpai J; Baldini E; Bauer S; Biagini R; Bielack S; Blay JY; Bonvalot S; Boukovinas I; Bovee JVMG; Boye K; Brodowicz T; Callegaro D; De Alava E; Deoras-Sutliff M; Dufresne A; Eriksson M; Errani C; Fedenko A; Ferraresi V; Ferrari A; Fletcher CDM; Garcia Del Muro X; Gelderblom H; Gladdy RA; Gouin F; Grignani G; Gutkovich J; Haas R; Hindi N; Hohenberger P; Huang P; Joensuu H; Jones RL; Jungels C; Kasper B; Kawai A; Le Cesne A; Le Grange F; Leithner A; Leonard H; Lopez Pousa A; Martin Broto J; Merimsky O; Merriam P; Miceli R; Mir O; Molinari M; Montemurro M; Oldani G; Palmerini E; Pantaleo MA; Patel S; Piperno-Neumann S; Raut CP; Ravi V; Razak ARA; Reichardt P; Rubin BP; Rutkowski P; Safwat AA; Sangalli C; Sapisochin G; Sbaraglia M; Scheipl S; Schöffski P; Strauss D; Strauss SJ; Sundby Hall K; Tap WD; Trama A; Tweddle A; van der Graaf WTA; Van De Sande MAJ; Van Houdt W; van Oortmerssen G; Wagner AJ; Wartenberg M; Wood J; Zaffaroni N; Zimmermann C; Casali PG; Dei Tos AP; Gronchi A
ESMO Open; 2021 Jun; 6(3):100170. PubMed ID: 34090171
[TBL] [Abstract][Full Text] [Related]
10. The management of desmoid tumours: A joint global consensus-based guideline approach for adult and paediatric patients.
Desmoid Tumor Working Group
Eur J Cancer; 2020 Mar; 127():96-107. PubMed ID: 32004793
[TBL] [Abstract][Full Text] [Related]
11. Retrospective Analysis of Outcome of Patients with Metastatic Leiomyosarcoma in a Tertiary Referral Center.
van Cann T; Cornillie J; Wozniak A; Debiec-Rychter M; Sciot R; Hompes D; Vergote I; Schöffski P
Oncol Res Treat; 2018; 41(4):206-213. PubMed ID: 29562223
[TBL] [Abstract][Full Text] [Related]
12. Clinical management and outcomes of primary ovarian leiomyosarcoma - Experience from a sarcoma specialist unit.
Cojocaru E; Palahepitiva Gamage G; Butler J; Barton DP; Thway K; Fisher C; Messiou C; Miah AB; Zaidi S; Gennatas S; Benson C; Huang P; Jones RL
Gynecol Oncol Rep; 2021 May; 36():100737. PubMed ID: 33732852
[TBL] [Abstract][Full Text] [Related]
13. Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first-line treatment for advanced leiomyosarcoma: A propensity score matching analysis from the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.
D'Ambrosio L; Touati N; Blay JY; Grignani G; Flippot R; Czarnecka AM; Piperno-Neumann S; Martin-Broto J; Sanfilippo R; Katz D; Duffaud F; Vincenzi B; Stark DP; Mazzeo F; Tuchscherer A; Chevreau C; Sherriff J; Estival A; Litière S; Sents W; Ray-Coquard I; Tolomeo F; Le Cesne A; Rutkowski P; Stacchiotti S; Kasper B; Gelderblom H; Gronchi A;
Cancer; 2020 Jun; 126(11):2637-2647. PubMed ID: 32129883
[TBL] [Abstract][Full Text] [Related]
14. Systemic treatment approaches for sporadic desmoid-type fibromatosis: scarce evidence and recommendations.
Kasper B
Oncol Res Treat; 2015; 38(5):244-8. PubMed ID: 25896775
[TBL] [Abstract][Full Text] [Related]
15. Leiomyosarcoma: Principles of management.
Martin-Liberal J
Intractable Rare Dis Res; 2013 Nov; 2(4):127-9. PubMed ID: 25343116
[TBL] [Abstract][Full Text] [Related]
16. Systemic Treatment of Metastatic/Recurrent Uterine Leiomyosarcoma: A Changing Paradigm.
Arend RC; Toboni MD; Montgomery AM; Burger RA; Olawaiye AB; Monk BJ; Herzog TJ
Oncologist; 2018 Dec; 23(12):1533-1545. PubMed ID: 30139839
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic advances in leiomyosarcoma.
Lacuna K; Bose S; Ingham M; Schwartz G
Front Oncol; 2023; 13():1149106. PubMed ID: 36969049
[TBL] [Abstract][Full Text] [Related]
18. On the road to improved outcomes by capturing leiomyosarcoma patients' views.
Jones RL
Future Oncol; 2022 Sep; 18(29s):3-11. PubMed ID: 36189762
[TBL] [Abstract][Full Text] [Related]
19. Treatment for leiomyosarcoma and leiomyoma in children with HIV infection.
Yin X; Wu T; Yan Y; Zhang H; Bu H
Cochrane Database Syst Rev; 2010 May; (5):CD007665. PubMed ID: 20464756
[TBL] [Abstract][Full Text] [Related]
20. Efficacy thresholds for clinical trials with advanced or metastatic leiomyosarcoma patients: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group meta-analysis based on a literature review for soft-tissue sarcomas.
Kantidakis G; Litière S; Neven A; Vinches M; Judson I; Schöffski P; Wardelmann E; Stacchiotti S; D'Ambrosio L; Marréaud S; van der Graaf WTA; Kasper B; Fiocco M; Gelderblom H
Eur J Cancer; 2021 Sep; 154():253-268. PubMed ID: 34298376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
